SA Pathology

Site

Women’s and Children’s Hospital Site

Accreditation No.

2348

Site No.

2487

Date of Accreditation

12 Oct 1988

Address

72 King William Road
North Adelaide, SA 5006
Australia

sapathology.sa.gov.au

Contact

Mr Jason Graefling P: +61 (08) 82223137

Availability

Services available to external clients

Supervision

GY (General)

Scope of Accreditation

Women’s and Children’s Hospital Site

ISO 15189 (2022)

  • This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.

Human Pathology

Medicare expiry date

29 Aug 2026

Last Activity Date

05 Sep 2024

Service Product Determinant
Anatomical pathology - Tissue pathology - Non-coronial autopsy services Body Autopsy service and reporting
Anatomical Pathology

ISO 15189 (2012)

Human Pathology

Medicare expiry date

29 Aug 2026

Last Activity Date

05 Sep 2024

Service Product Determinant
Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy Other body fluids; Sputum; Urine; Washings or brushings from other sites Cytological examination; Review and reporting of cytology samples
Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsy Fine needle aspirates (FNA) Cytological examination; Review and reporting of fine needle aspiration samples
Anatomical pathology - Tissue pathology - Coronial autopsy services Body; Body parts Autopsy service and reporting
Anatomical pathology - Tissue pathology - Examination of biopsy material Formalin-fixed tissue Review and reporting of biopsy material to identify or exclude morphological abnormalities
Anatomical pathology - Tissue pathology - Immediate frozen section diagnosis Fresh tissue Intra-operative consultation and examination of biopsy material
Anatomical pathology - Tissue pathology - Immunohistochemical (immunofluorescence) investigationReporting only Formalin-fixed paraffin-embedded (FFPE) tissues Detection of antigenic targets - Various
Formalin-fixed paraffin-embedded (FFPE) tissues; Fresh tissue; Frozen tissue Detection of antigenic targets - Various
Anatomical pathology - Tissue pathology - Mortuary facilities Body; Body parts Assessment - Level 3 mortuary
Anatomical pathology - Tissue pathology - Non-coronial autopsy servicesStatewide and Northern Territory Perinatal Autopsy Service Body; Body parts Autopsy service and reporting
Antenatal Screening Laboratory

ISO 15189 (2012)

Human Pathology

Medicare expiry date

29 Aug 2026

Last Activity Date

05 Sep 2024

Service Product Determinant
Chemical pathology - Investigation of maternal markers to detect foetal abnormalityReporting only Serum Oestriol - Unconjugated
Automated Laboratory

ISO 15189 (2012)

Human Pathology

Medicare expiry date

29 Aug 2026

Last Activity Date

05 Sep 2024

Service Product Determinant
Haematology - Assessment of haemolysis or metabolic enzymes (red cell enzyme assays) Blood Glucose-6-phosphate dehydrogenase (G6PD)
Microbiology - Bacteriology - Detection of pathogenic bacteria Cerebrospinal fluid (CSF) Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC)
Urine Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC)
Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) Nasal swabs Methicillin resistant Staphylococcus aureus (MRSA)
Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) Nasal swabs; Nasopharyngeal swabs Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) - PCR, RT-PCR
Nasal swabs; Nasopharyngeal swabs; Throat swabs Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) - PCR, RT-PCR
Core Laboratory – Biochemistry

ISO 15189 (2012)

Human Pathology

Medicare expiry date

29 Aug 2026

Last Activity Date

05 Sep 2024

Service Product Determinant
Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals Plasma; Serum Ethanol; Paracetamol (acetaminophen)
Chemical pathology - Biochemical genetic services for the diagnosis of metabolic and enzymological disorders Blood; Cerebrospinal fluid (CSF) Pyruvate or other amino acids
Plasma Free fatty acids - Total
Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring Plasma; Serum Amikacin; Gentamicin (cidomycin, septopal, genticyn, garamycin); Methotrexate; Salicylate; Tobramycin
Vancomycin
Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) Plasma; Serum Procalcitonin
Chemical pathology - Diagnosis and management of diabetes mellitus Blood Glycated haemoglobin (HbA1c)
Chemical pathology - Further investigation of cardiac function Plasma; Serum Troponin T
Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia Plasma; Serum HDL - Quantitation
Chemical pathology - Further investigation of renal and/or hepatic function Plasma; Serum Bile acids - Quantitative
Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies Cerebrospinal fluid (CSF) Glucose; Lactate; Protein - Total
Plasma; Serum Alanine aminotransferase; Albumin; Alkaline phosphatase; Aspartate aminotransferase; Bicarbonate; Bilirubin - Conjugated; Bilirubin - Total; C-reactive protein (CRP); Calcium - Total; Chloride; Cholesterol - Total; Creatine kinase; Creatinine; Glucose; Lactate dehydrogenase (LDH); Lipase; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urate; Urea; γ-Glutamyltransferase
Ammonia; Lactate
Plasma; Serum; Urine Osmolality
Urine Albumin; Calcium - Total; Chloride; Creatinine; Glucose; Potassium; Protein - Total; Sodium; Urate; Urea
Chemical pathology - Investigation of maternal markers for pre-eclampsia Serum FMS-like tyrosine kinase 1 - Soluble; Placental growth factor (PGF, PLGF)
Chemical pathology - Iron studies Plasma; Serum Ferritin; Iron; Transferrin
Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) Blood Bicarbonate; Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH
Chemical pathology - Tests for thyroid function Plasma; Serum Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free
Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy Plasma; Serum Human chorionic gonadotropin (hCG) - Quantitative total
Cytogenetics

ISO 15189 (2012)

Human Pathology

Medicare expiry date

29 Aug 2026

Last Activity Date

05 Sep 2024

Service Product Determinant
Chemical pathology - Biochemical genetic services for the diagnosis of metabolic and enzymological disorders Tissues Tissue culture and long term storage
Cytogenetics - Detection of defined, balanced and/or unbalanced chromosomal abnormalities by in situ hybridisation techniques Amniotic fluid; Blood; Other body fluids; Tissues Cytogenetic analysis and reporting
Cytogenetics - Molecular karyotype (SNP microarray) detection of unbalanced chromosome abnormalities Amniotic fluid; Blood; Other body fluids; Tissues Cytogenetic analysis and reporting
Cytogenetic analysis and reporting
Diabetes clinic

ISO 15189 (2012)

Human Pathology

Medicare expiry date

29 Aug 2026

Last Activity Date

05 Sep 2024

Service Product Determinant
Chemical pathology - Diagnosis and management of diabetes mellitus Blood Glycated haemoglobin (HbA1c)
Endocrine Department

ISO 15189 (2012)

Human Pathology

Medicare expiry date

29 Aug 2026

Last Activity Date

05 Sep 2024

Service Product Determinant
Chemical pathology - Diagnosis and management of diabetes mellitus Blood Glycated haemoglobin (HbA1c)
Haematology

ISO 15189 (2012)

Human Pathology

Medicare expiry date

29 Aug 2026

Last Activity Date

05 Sep 2024

Service Product Determinant
Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals Blood; Swabs; Urine Snake venom detection
Haematology - Bone marrow examination Bone marrow Examination of aspirated material
Haematology - Foetal haemoglobin in maternal circulation Blood Presence of foetal red blood cells
Haematology - Full blood examination Blood Differential number; Morphology
Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Platelet count; Red blood cell index or indices; Reticulocyte haemoglobin equivalent (Ret-He); Reticulocytes
Cerebrospinal fluid (CSF) Differential number; Erythrocyte count (red blood cell count, RBCC)
Fluids Differential number; Erythrocyte count (red blood cell count, RBCC); Leucocyte count (white blood cell count, WBCC)
Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) Blood Anti-Xa activity - Unfractionated heparin
Viscoelastic haemostatic testing (VHT)
Platelet aggregation
International normalised ratio (INR)
Plasma Factor IX; Factor VIII
Activated partial thromboplastin time (APTT); D-dimer; Fibrinogen; International normalised ratio (INR); Prothrombin time (PT)
Haematology - Limited blood examination Blood Erythrocyte (RBC) sedimentation rate (ESR)
Microbiology - Parasitology - Detection of ova, cysts and parasites Blood Malaria
Immunology

ISO 15189 (2012)

Human Pathology

Medicare expiry date

29 Aug 2026

Last Activity Date

05 Sep 2024

Service Product Determinant
Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) Blood; Cerebrospinal fluid (CSF); Disaggregated tissues specimen CD16; CD19; CD2; CD20; CD3; CD4; CD56; CD8; HLA-DR antigen
Immunopathology - Investigation and/or assessment of neutrophils - Functional tests Blood Qualitative assessment of neutrophils for the presence of oxidative pathway defects
Serum Quantitative assessment of oxidative pathways
Immunopathology - Investigation of natural killer cell release from target cells Blood Natural killer (NK) cell cytotoxicity; Natural killer (NK) cell number
Immunopathology - Quantitative and/or qualitative investigation of proteins Cell culture medium; Serum Cytokines
Immunopathology - Quantitative investigation and/or assessment of neutrophils Polymorphonuclear cells Chemotaxis
Immunopathology - Tests of cellular immunity - Lymphocyte function tests Blood Bruton's tyrosine kinase (BTK); CD11b; CD18; CD40; CD40L; CD45R (B220); CD69; Interferon-γ (IFN-γ); Lymphocyte quantitation; T-cell receptor αβ-1 (TCRαβ1)
Proliferation by antigens; Proliferation by mitogens
Proliferation by antigens; Proliferation by mitogens
Labour Ward

ISO 15189 (2012)

Human Pathology

Medicare expiry date

29 Aug 2026

Last Activity Date

05 Sep 2024

Service Product Determinant
Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) Blood Bicarbonate; Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH
Metabolic Laboratory

ISO 15189 (2012)

Human Pathology

Medicare expiry date

29 Aug 2026

Last Activity Date

05 Sep 2024

Service Product Determinant
Chemical pathology - Biochemical genetic services for the diagnosis of metabolic and enzymological disorders Amniocytes; Blood; Chorionic villus; Plasma; Serum; Tissues 7-Dehydrocholesterol; Neutral sterols
Blood; Cell culture; Plasma; Serum; Tissues Phytanic acid; Pristanic acid; Very long chain fatty acids (vLCFA)
Blood; Erythrocytes (red blood cells, RBC) Plasmalogens
Cerebrospinal fluid (CSF); Plasma; Urine Amino acids
Glycosaminoglycans (MPS)Non reducing end fragments
Plasma Methylmalonic acid (MMA)
Plasma; Urine Carnitine - Free; Carnitines
Creatine and guanidinoacetate
Urine Trimethylamine
Organic acids
Purines and pyrimidines; s-Sulfocysteine
Sulfatide
Glycosaminoglycans (MPS)
Bile acid profile
Tetrasaccharide
Orotic acid
Chemical pathology - Dynamic tests Sweat Sweat tests
Molecular Genetics

ISO 15189 (2012)

Human Pathology

Medicare expiry date

29 Aug 2026

Last Activity Date

05 Sep 2024

Service Product Determinant
Molecular genetics - Estimation of risk of inheritance of an unknown mutation (Bayesian and linkage calculations) Amniotic fluid; Blood; Chorionic villus Angelman syndrome; Fragile X; Maternal cell contamination; Myotonic dystrophy; Prader-Willi syndrome; Spinal muscular atrophy; Uniparental disomy
Molecular genetics - Investigation of constitutional genetic variants - Carrier testing - Targeted genes Amniotic fluid; Blood; Chorionic villus Angelman syndrome; Duchenne-Becker muscular dystrophy; Fragile X; Fragile XE mental retardation; Friedreich's ataxia (FRDA, FA); Incontinentia pigmenti; Kennedy's disease (spinal and bulbar muscular atrophy); Myotonic dystrophy; Prader-Willi syndrome; Spinal muscular atrophy; Spinocerebellar ataxia
Amniotic fluid; Blood; Chorionic villus; Leucocytes (leukocytes); Skin fibroblasts Canavan disease; Congenital disorder of glycosylation type 1a; Cystic fibrosis; D-bifunctional protein (DBP) deficiency; Fabry disease; Galactosemia; Gaucher disease; Glycogen storage disease type II (Pompe disease); Hexosaminidase A deficiency (Tay Sachs disease); Krabbe disease; Long chain 3-hydroxyacyl-coenzyme A dehydrogenase (LHCAD) deficiency; Medium chain acyl-coenzyme A dehydrogenase (MCAD); Metachromatic leukodystrophy (MLD, arylsulfatase A deficiency); Mucopolysaccharidosis diseases - MPS I, MPS II, MPS IIIA, IIIB, IVA, VI; Neuronal ceroid lipofuscinosis; Niemann-Pick disease type C; Rhizomelic chondrodysplasia punctata; Roche 1K disease; Smith-Lemli-Opitz syndrome; X-linked adrenoleukodystrophy; Zellweger
Molecular genetics - Investigation of constitutional genetic variants - Diagnostic testing - Targeted genes Amniotic fluid; Blood; Chorionic villus Angelman syndrome; Duchenne-Becker muscular dystrophy; Fragile X; Fragile XE mental retardation; Friedreich's ataxia (FRDA, FA); Incontinentia pigmenti; Kennedy's disease (spinal and bulbar muscular atrophy); Myotonic dystrophy; Prader-Willi syndrome; Spinal muscular atrophy; Spinocerebellar ataxia
Blood; Leucocytes (leukocytes); Skin fibroblasts; Tissues Canavan disease; Congenital disorder of glycosylation type 1a; Cystic fibrosis; D-bifunctional protein (DBP) deficiency; Fabry disease; Galactosemia; Gaucher disease; Glycogen storage disease type II (Pompe disease); Hexosaminidase A deficiency (Tay Sachs disease); Krabbe disease; Long chain 3-hydroxyacyl-coenzyme A dehydrogenase (LHCAD) deficiency; Medium chain acyl-coenzyme A dehydrogenase (MCAD); Metachromatic leukodystrophy (MLD, arylsulfatase A deficiency); Mucopolysaccharidosis diseases - MPS I, MPS II, MPS IIIA, IIIB, IVA, VI; Neuronal ceroid lipofuscinosis; Niemann-Pick disease type C; Rhizomelic chondrodysplasia punctata; Roche 1K disease; Smith-Lemli-Opitz syndrome; X-linked adrenoleukodystrophy; Zellweger
Molecular genetics - Investigation of constitutional genetic variants - Diagnostic testing - Targeted panels for inherited (germline) DNA/RNA changes Blood Copy number variation (CNV); Indels; Single nucleotide variants (SNVs)
Molecular genetics - Investigation of constitutional genetic variants - Diagnostic testing - Whole exome sequencing studies for inherited (germline) DNA/RNA changes Blood Copy number variation (CNV); Indels; Single nucleotide variants (SNVs)
Molecular genetics - Prenatal genetic testing (excluding non-invasive prenatal [genetic] screening) Amniotic fluid; Blood; Chorionic villus Canavan disease; Classic infantile diseases - CLN1, CLN2, CLN3; Congenital disorder of glycosylation type 1a; Cystic fibrosis; D-bifunctional protein (DBP) deficiency; Fabry disease; Galactosemia; Gaucher disease; Glycogen storage disease type II (Pompe disease); Hexosaminidase A deficiency (Tay Sachs disease); Krabbe disease; Long chain 3-hydroxyacyl-coenzyme A dehydrogenase (LHCAD) deficiency; Medium chain acyl-coenzyme A dehydrogenase (MCAD); Metachromatic leukodystrophy (MLD, arylsulfatase A deficiency); Mucopolysaccharidosis diseases - MPS I, MPS II, MPS IIIA, IIIB, IVA, VI; Niemann-Pick disease; Rhizomelic chondrodysplasia punctata; Roche 1K disease; Smith-Lemli-Opitz syndrome; X-linked adrenoleukodystrophy; Zellweger
Angelman syndrome; Duchenne-Becker muscular dystrophy; Fragile X; Fragile XE mental retardation; Friedreich's ataxia (FRDA, FA); Incontinentia pigmenti; Kennedy's disease (spinal and bulbar muscular atrophy); Myotonic dystrophy; Prader-Willi syndrome; Spinal muscular atrophy; Spinocerebellar ataxia
Molecular genetics - Screening for an unknown mutation - Targeted genes Blood Familial Mediterranean fever; Prelingual deafness
Molecular genetics/Cytogenetics - Bioinformatic analysis DNA sequences; RNA sequences Secondary analysis - Alignment and variant calling; Tertiary analysis - Data annotation and interpretation
National Referral Laboratory

ISO 15189 (2012)

Human Pathology

Medicare expiry date

29 Aug 2026

Last Activity Date

05 Sep 2024

Service Product Determinant
Chemical pathology - Biochemical genetic services for the diagnosis of metabolic and enzymological disorders Blood Gal-1-p-uridyl transferase; Galactokinase; Galactose-1-phosphate
Cerebrospinal fluid (CSF); Plasma; Urine Glycosaminoglycans - Non-reducing end fragments (MPS)
Glycosaminoglycans - Non-reducing end fragments (MPS)
Dried blood spots Glucosylsphingosine
Liver Glucose-6-phosphatase
Liver; Muscle Phosphorylase - Total; Phosphorylase a; Phosphorylase b kinase
Muscle Carnitine palmitoyl transferase I; Carnitine palmitoyl transferase II
Plasma 18:0 Sulfatide; Glucosylsphingosine; Lyso-ceramidetrihexoside; Lysosphinogomyelin 509
Urine Oligosaccharides
Glycosaminoglycans (MPS); Tetrasaccharide
Chemical pathology - Newborn screening services for the diagnosis of inborn errors of metabolism Amniocytes; Blood; Chorionic villus; Leucocytes (leukocytes); Plasma; Skin fibroblasts Acid phosphatase; α-Fucosidase; α-Mannosidase; α-n-Acetylgalactosaminidase; β-Galactosidase; β-Glucuronidase; β-Hexosamindase - Total; β-Hexosamindase A (MUGS)
Arylsulfatase A
Amniocytes; Blood; Chorionic villus; Leucocytes (leukocytes); Skin fibroblasts Galactose-6-sulfatase; Iduronate-2-sulfatase; Sulfamidase; α-Iduronidase
Phosphomannnoisomerase; Phosphomannomutase
Acid lipase; Sphingomyelinase; n-Acetylglucosamine-6-sulfatase; α-n-Acetylglucosaminidase; β-Galactocerebrosidase; β-Glucocerebrosidase
n-Acetylgalactosamine-4-sulfatase
Palmitoyl protein thioesterase; Sulfatase - Total; Tripeptidyl peptidase; α-Galactosidase A
Amniocytes; Blood; Leucocytes (leukocytes); Skin fibroblasts Dehydroepiandrosterone sulfate (DHEAS) sulfatase
Amniocytes; Chorionic villus; Dried blood spots; Muscle; Skin fibroblasts α-Glucosidase
Amniocytes; Chorionic villus; Skin fibroblasts Hypoxanthine/guanine phosphoribosyl transferase
Ceremidase; Citrulline; Cystine; Debrancher enzyme; Dihydroacetonephosphate acyltransferase; Dihydroacetonephosphate alkyl synthase; Gal-1-p-uridyl transferase; Leucine decarboxylation; Neuraminidase; Phytanic acid oxidase
Catalase
Amniocytes; Chorionic villus; Skin fibroblasts; Urine n-Acetylneuraminic acid (sialic acid, NANA)
Blood Adenine phosphoribosyl transferase
Blood; Leucocytes (leukocytes); Serum n-Acetyl-β-glucosaminidase
β-Hexosaminidase - Heat inactivated
Dried blood spots α-Glucosidase
α-Galactosidase A
Liver Carbamoyl-phosphate synthetase; Ornithine transcarbamylase
Molecular genetics/Cytogenetics - Bioinformatic analysis DNA sequences; RNA sequences Secondary analysis - Alignment and variant calling; Tertiary analysis - Data annotation and interpretation
Neonatal Intensive Care Unit

ISO 15189 (2012)

Human Pathology

Medicare expiry date

29 Aug 2026

Last Activity Date

05 Sep 2024

Service Product Determinant
Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) Blood Bicarbonate; Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH
Neonatal Screening Centre

ISO 15189 (2012)

Human Pathology

Medicare expiry date

29 Aug 2026

Last Activity Date

05 Sep 2024

Service Product Determinant
Chemical pathology - Newborn screening services for the diagnosis of inborn errors of metabolism Dried blood spots Acylcarnitine profile; Amino acids
Gal-1-p-uridyl transferase; Galactose; Galactose-1-phosphate
Methylmalonic acid (MMA)
Immunoreactive trypsin; Thyroid stimulating hormone (TSH)
Paediatric Emergency Unit

ISO 15189 (2012)

Human Pathology

Medicare expiry date

29 Aug 2026

Last Activity Date

05 Sep 2024

Service Product Determinant
Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) Blood Bicarbonate; Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH
Paediatric Intensive Care Unit

ISO 15189 (2012)

Human Pathology

Medicare expiry date

29 Aug 2026

Last Activity Date

05 Sep 2024

Service Product Determinant
Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) Blood Bicarbonate; Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH
Patient Services/Blood Collection

ISO 15189 (2012)

Human Pathology

Medicare expiry date

29 Aug 2026

Last Activity Date

05 Sep 2024

Service Product Determinant
Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) Blood International normalised ratio (INR)
Postnatal Unit

ISO 15189 (2012)

Human Pathology

Medicare expiry date

29 Aug 2026

Last Activity Date

05 Sep 2024

Service Product Determinant
Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) Blood Bicarbonate; Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH
Salmonella Reference Laboratory

ISO 15189 (2012)

Human Pathology

Medicare expiry date

29 Aug 2026

Last Activity Date

05 Sep 2024

Service Product Determinant
Microbiology - Bacteriology - Detection of pathogenic bacteria Bacterial isolates Bacteria; Pathogenic identification; Pathogenic microorganisms
Bacteria; Pathogenic identification; Pathogenic microorganisms
Bacteria; Pathogenic identification; Pathogenic microorganisms
Bacteria; Pathogenic microorganisms
Microbiology - Bacteriology - Public health investigation and/or monitoring of outbreaks of infection Isolates Detection and characterisation of bacteria (including identification and typing)
Special Care Baby Unit 2

ISO 15189 (2012)

Human Pathology

Medicare expiry date

29 Aug 2026

Last Activity Date

05 Sep 2024

Service Product Determinant
Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) Blood Bicarbonate; Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH
Special Care Baby Unit 3

ISO 15189 (2012)

Human Pathology

Medicare expiry date

29 Aug 2026

Last Activity Date

05 Sep 2024

Service Product Determinant
Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) Blood Bicarbonate; Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH
Transfusion

ISO 15189 (2012)

Human Pathology

Medicare expiry date

29 Aug 2026

Last Activity Date

05 Sep 2024

Service Product Determinant
Immunohaematology - Blood group antibody detection Blood; Plasma Other blood group systems; Rh phenotypes
Immunohaematology - Blood grouping Blood ABO; RhD
Immunohaematology - Determination of compatibility of blood donor units Blood Direct antiglobulin test (DAT, direct Coombs test)
Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies
Immunohaematology - Identification and quantitation of blood group antibodies Blood Antibody elution
Blood; Plasma Other blood group antibodies; Red blood cell phenotyping; Rh
Plasma Antibody titration
Immunohaematology - Investigation of blood transfusion reactions Blood products Antibodies
Immunohaematology - Issue and release of blood and blood product for transfusion Blood; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets Issue and release of blood and blood products for transfusion
Immunohaematology - Storage and distribution of blood and blood components Blood; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets Compliance with transport, storage and distribution requirements of blood, products and components
Women’s Assessment

ISO 15189 (2012)

Human Pathology

Medicare expiry date

29 Aug 2026

Last Activity Date

05 Sep 2024

Service Product Determinant
Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) Blood Bicarbonate; Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH

The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.